Furthermore, by blocking Pin1, therapy based on a combination of ATO and all-trans retinoic acid (ATRA) has been proven effective against tumor-initiating cells, particularly in triple-negative breast cancer (70). This evidence concerns the gene PIN1 and neoplasm.